A method for inhibiting cancer development by fatty acid synthase inhibitors
Details for Australian Patent Application No. 2003287380 (hide)
International Classifications
Event Publications
1 April 2004 Complete Application Filed
Priority application(s): 60/422,746 31.10.02 US
1 July 2004 Application Open to Public Inspection
Published as AU-B-2003287380
28 May 2009 Application Accepted
Published as AU-B-2003287380
18 June 2009 Alteration of Name
The name of the applicant has been altered to Fasgen LLC; The Johns Hopkins University
9 July 2009 Corrigenda
Applications Accepted - Name Index Under the name Fasgen LLC and The Johns Hopkins University, Application No. 2003287380, under INID(72) correct the co-inventor name to Kuhajda, Francis Paul
24 September 2009 Standard Patent Sealed
26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003287381-Composition for the treatment of macular degenration
2003287379-SYSTEM AND METHOD FOR COMMUNICATING WITH A VOLTAGE REGULATOR
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser